Accomplished professional adept at driving team performance, business strategies, and making data-supported recommendations for continuous process improvement. Skilled at identifying optimal tactics for motivating teams and engaging clients.
Overview
10
10
years of professional experience
Work History
Senior Manager
AdametNext
Gurugram
07.2021 - Current
Coordinated with internal departments to ensure the successful execution of projects within the timelines
Tracked project progress against schedule timelines while ensuring compliance with established quality standards.
Built a digital service portfolio from scratch and delivered multiple projects for big and mid-pharma customers
Led multiple client engagements involving, secondary research, conference coverage, social media listening, influencer analysis, KOL Mapping, etc
Attended medical conferences to draw meaningful insights for the customers
Identified areas of improvement within existing operations through process analysis and benchmarking studies.
Participated in recruitment initiatives by interviewing potential candidates and selecting suitable hires.
Developed long-term relationships with key stakeholders
Planned and delivered training sessions to improve employee effectiveness and address areas of weakness.
Assistant Manager
WNS (GSK Knowledge Centre)
Gurugram
09.2017 - 06.2021
Competitive intelligence – analysis of pharmaceutical products based on comparative parameters as well as defining, gathering, analyzing information about products, customers, competitors and any aspect of the environment needed to make strategic decisions for an organization
Medical Conference Coverage: Onsite and Virtual multiple conference coverage. Examples - ID Week, ASCO, ESMO, AASLD, RNA Society, AAN, EAN, ASH etc
Medical Affairs dashboards: Set up an entirely new team at the offshore for GSK European Medical Affairs with dashboards on Tableau, Excel
Therapy landscape: Detailed analysis across different therapies across US, Europe and Japan
Global launch and approval analysis: product launch and approval analysis by using different models, analogs and tools created primarily by the CI team
Strategic Competitive Intelligence Update Reports: Monthly updates around the competitor activities with insights generated internally as well as from information provided by onshore stakeholders
Business development projects: Supports the development of proposals and other business development materials, worked on different oncology projects including Cell engagers, Functional Genomics, Immunology
landscapes etc.
Associate Consultant
Moody's Analytics
Gurugram
06.2016 - 09.2017
Clinical trials assessment - Assessment of clinical trials design, end points and study populations to help drive product analysis using clinicalrials.gov, UMIN clinical trials, EudraCT (Europe) and JAPIC (Japan)
Analyst perspectives reports – includes the analyst recommendation pages that holds the buy, sell and hold analysis as well as the analyst or the broker commentary section
Annotated stock price analysis of healthcare companies – annotating the various events impacting the share price movements of the company over a period of time
Benchmarking studies - engages in benchmarking studies using various parameters such as primary and secondary end points result of clinical trials; overall response rate; complete response rates, duration of response, peak sales etc.
Senior Business Analyst
WNS
Gurugram
03.2014 - 06.2016
Analyzing Company Pipeline - Preparing as well as analyzing reports including detailed description of R&D as well as marketed products portfolio, forecasting, sales revenue, M&As, patent & litigation data etc
Patent & Clinical Trials Research - Tracking patent litigations among pharmaceutical companies, in-depth processing & analysis of clinical trials (especially USA based & registered on www.clinicaltrials.gov)
Tracking News & Events - Analyses of conferences, industry event and press releases from Pharmaceutical & Biotech companies to update database and companies portfolios
Sales & R&D Data - Conducting secondary research from company SEC filings, quarterly or half yearly results press releases, annual reports, presentations to update company portfolio and sales forecast